UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Establishing value in managed care: Cost-effectiveness or budgetary impact?: Integration of basic science, clinical and economic research in pharmacologic decision-making: optimizing value in asthma management

Journal of allergy and clinical immunology, 2002, Vol.109 (5), p.S511-S513

CLOUSE, Jon

2002

Volltextzugriff (PDF)

Establishing value in managed care: Cost-effectiveness or budgetary impact?

Journal of allergy and clinical immunology, 2002-05, Vol.109 (5), p.S511-S513

Clouse, Jon

2002

Volltextzugriff (PDF)

Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective

Value in health, 2001-07, Vol.4 (4), p.329-334

2001

Volltextzugriff (PDF)

Healthcare resource use and costs associated with migraine in a managed healthcare setting

The Annals of pharmacotherapy, 1994-05, Vol.28 (5), p.659

1994

Volltextzugriff (PDF)

Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting

Clinical therapeutics, 2000, Vol.22 (1), p.91-102

2000

Volltextzugriff (PDF)

Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations

Pharmacoepidemiology and drug safety, 2000-12, Vol.9 (7), p.549-556

2000

Volltextzugriff (PDF)

Financial incentives and drug spending in managed care

Health affairs (Millwood, Va.), 1999-03, Vol.18 (2), p.189-200

1999

Volltextzugriff (PDF)

Using Claims Data for Epidemiologic Research: The Concordance of Claims-Based Criteria with the Medical Record and Patient Survey for Identifying a Hypertensive Population

Medical care, 1993-06, Vol.31 (6), p.498-507

1993

Volltextzugriff (PDF)

The Effect of Methodological Advances in Health Economics on the Marketplace

Therapeutic innovation & regulatory science, 1995, Vol.29 (4), p.1429-1430

Clouse, Jon

1995

Volltextzugriff (PDF)

Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone)

Journal of clinical psychopharmacology, 1992-02, Vol.12 (1), p.19-26

1992

Volltextzugriff (PDF)

Incidence of adverse oesophageal and gastric events in alendronate users

Pharmacoepidemiology and drug safety, 2000-09, Vol.9 (5), p.371-376

2000

Volltextzugriff (PDF)

One-year costs of second-line therapies for depression

The journal of clinical psychiatry, 2000-04, Vol.61 (4), p.290

2000

Volltextzugriff (PDF)

Health economic considerations in the management of type 2 diabetes

Managed care interface, 2002-01, Vol.15 (1), p.66

2002

Volltextzugriff (PDF)

Panel 5: Application of Healthcare Intervention Economic Evaluations in Healthcare Decision-Making

Value in health, 1999-03, Vol.2 (2), p.92-98

1999

Volltextzugriff (PDF)

Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression

PharmacoEconomics, 1999-05, Vol.15 (5), p.495-505

1999

Volltextzugriff (PDF)

Pharmacoeconomics: Identifying the Issues Overview and Advisory Panel Report Summary

Value in health, 1999-03, Vol.2 (2), p.67-72

1999

Volltextzugriff (PDF)

Treatment of Comorbid Deneralized Anxiety in a Recently Detoxified Alcoholic Population with a Selective Serotonergie Drug (Buspirone)

Current opinion in cardiology, 1992-02, Vol.7 (1), p.19-26

1992

Volltextzugriff (PDF)

Pharmacokinetic properties of maprotiline in geriatric depression

Journal of clinical psychopharmacology, 1989-08, Vol.9 (4), p.313-314

1989

Volltextzugriff (PDF)

Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxiety

Journal of clinical psychopharmacology, 1989-04, Vol.9 (2), p.132-136

1989

Volltextzugriff (PDF)

EFFECTS OF AEROSOL OT ON THE PHASE SEPARATION TEMPERATURES OF METHANOL/HYDROCARBON/WATER BLENDS

Fuel science & technology international, 1994-01, Vol.12 (9), p.1271-1279

1994

Volltextzugriff (PDF)

One-year results of the GORE EXCLUDER Conformable AAA Endoprosthesis system in the United States regulatory trial

Journal of vascular surgery, 2022-10, Vol.76 (4), p.951-959.e2

2022

Volltextzugriff (PDF)

Comparison of coronary plaque subtypes in male and female patients using 320-row MDCTA

Atherosclerosis, 2013-02, Vol.226 (2), p.428-432

2013

Volltextzugriff (PDF)

1324 QUANTIFICATION OF LIVER FAT USING NON-CONTRAST CT: COMPARISON OF LIVER/SPLEEN RATIO (CTLS), LIVER-SPLEEN DIFFERENCE (CTL − T) WITH LIVER FAT PERCENTAGE (CTLFP)

Journal of hepatology, 2013-04, Vol.58, p.S534-S534

2013

Volltextzugriff (PDF)

Assessment of liver fat in an obese patient population using noncontrast CT fat percent index

Clinical imaging, 2014-05, Vol.38 (3), p.259-264

2014

Volltextzugriff (PDF)

Upper Extremity Vascular Injury: A Current In-Theater Wartime Report from Operation Iraqi Freedom

Annals of vascular surgery, 2006-07, Vol.20 (4), p.429-434

2006

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Establishing value in managed care: Cost-effectiveness or budgetary impact?: Integration of basic science, clinical and economic research in pharmacologic decision-making: optimizing value in asthma management

Establishing value in managed care: Cost-effectiveness or budgetary impact?

Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective

Healthcare resource use and costs associated with migraine in a managed healthcare setting

Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting

Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations

Financial incentives and drug spending in managed care

Using Claims Data for Epidemiologic Research: The Concordance of Claims-Based Criteria with the Medical Record and Patient Survey for Identifying a Hypertensive Population

The Effect of Methodological Advances in Health Economics on the Marketplace

Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone)

Incidence of adverse oesophageal and gastric events in alendronate users

One-year costs of second-line therapies for depression

Health economic considerations in the management of type 2 diabetes

Panel 5: Application of Healthcare Intervention Economic Evaluations in Healthcare Decision-Making

Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression

Pharmacoeconomics: Identifying the Issues Overview and Advisory Panel Report Summary

Treatment of Comorbid Deneralized Anxiety in a Recently Detoxified Alcoholic Population with a Selective Serotonergie Drug (Buspirone)

Pharmacokinetic properties of maprotiline in geriatric depression

Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxiety

EFFECTS OF AEROSOL OT ON THE PHASE SEPARATION TEMPERATURES OF METHANOL/HYDROCARBON/WATER BLENDS

One-year results of the GORE EXCLUDER Conformable AAA Endoprosthesis system in the United States regulatory trial

Comparison of coronary plaque subtypes in male and female patients using 320-row MDCTA

1324 QUANTIFICATION OF LIVER FAT USING NON-CONTRAST CT: COMPARISON OF LIVER/SPLEEN RATIO (CTLS), LIVER-SPLEEN DIFFERENCE (CTL − T) WITH LIVER FAT PERCENTAGE (CTLFP)

Assessment of liver fat in an obese patient population using noncontrast CT fat percent index

Upper Extremity Vascular Injury: A Current In-Theater Wartime Report from Operation Iraqi Freedom

Suchergebnisse filtern